Filing Details

Accession Number:
0001437749-25-013198
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-25 21:36:52
Reporting Period:
2025-04-23
Filing Date:
2025-04-25
Accepted Time:
2025-04-25 21:36:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
925741 Biocardia Inc. BCDA Biological Products, (No Disgnostic Substances) (2836) 232753988
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789894 Scott Andrew Blank C/O Biocardia, Inc.
320 Soquel Way
Sunnyvale CA 94085
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-04-23 131,233 $1.91 265,957 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2025-04-23 131,233 $0.00 131,233 $1.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
242,233 2025-04-23 2030-04-23 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,812 Direct
Footnotes
  1. On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.
  2. These shares are held by Andy Blank Revocable Living Trust, of which the Reporting Person serves as trustee.